Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New “Ideal Japan” Program
Business Wire India After 20 years of the prestigious JCA (Japanese Cancer Association) Mauvernay Award in Japan, Debiopharm is now transitioning its longstanding support for Japanese research to the new…